Articles tagged with: Treatment
Resources, Treatments »
| Brand Name: | Invirase |
| Generic Name: | saquinavir mesylate |
| Company: | Hoffman-La Roche |
| FDA Clinical Phase: | Approved in 1995 for the treatment of HIV-1 infection |
Description
Invirase (saquinavir mesylate) is part of a class of anti-HIV drugs known as Protease Inhibitors (PIs). By inhibiting the action of protease, an enzyme, Invirase ensures that replicated viruses cannot infect other CD4 cells. CD4 cells, also known as T cells, are a special type of white blood…
Resources, Treatments »
| Brand Name: | Fuzeon |
| Generic Name: | enfuvirtide |
| Company: | Hoffmann-La Roche Inc. (Roche Pharmaceuticals) |
| FDA Clinical Phase: | Approved for use in 2003 in combination with other HIV drugs to increase CD4 cell count (“helper T-cells”) and decrease viral load (number of HIV copies in a blood sample). |
Description
Fuzeon is the first fusion inhibitor approved by the U.S. Food and Drug Administration for patients who have already started antiretroviral therapy for HIV infection. Fusion inhibitors…
Featured, Resources »
Currently, there is no vaccine or cure for HIV or AIDS. The best method of prevention is to avoid exposure to the virus.
Antiviral Treatment
Anti-HIV (antiretroviral) medications are used to slow down reproduction and hinder progression of the virus.
For individuals recently exposed to HIV, an antiretroviral treatment called post-exposure prophylaxis (PEP) is recommended. Prophylaxis means disease prevention, thus the main purpose of PEP is to prevent HIV infection after exposure. PEP treatment should begin as soon as possible after the exposure. PEP has a very strict schedule of…